Asherman JG. Traumatic intra-uterine adhesions. J Obstet Gynaecol Br Emp. 1950;57:892–6.
Wang Y, Yao Z, Zhao H, Yue C, Yu Q, Zhang Y, Guo Z, Xu Z, Zhang L, Yan L. Reproductive outcomes of in vitro fertilization-intracytoplasmic sperm injection after transcervical resection of adhesions: a retrospective cohort study. J Minim Invasive Gynecol. 2020. https://doi.org/10.1016/j.jmig.2020.10.029.
Hooker AB, de Leeuw RA, Twisk JWR, Brölmann HAM, Huirne JAF. Reproductive performance of women with and without intrauterine adhesions following recurrent dilatation and curettage for miscarriage: long-term follow-up of a randomized controlled trial. Hum Reprod. 2020. https://doi.org/10.1093/humrep/deaa289.
Chawla L, Prateek S, Bahadur A, Durgapal P. Intrauterine adhesions with secondary amenorrhea: A notable indicator of endometrial tuberculosis. Indian J Tuberc. 2020;67:575–7.
March CM. Management of Asherman’s syndrome. Reprod Biomed Online. 2011;23:63–76.
Wang L, Yu C, Chang T, Zhang M, Song S, Xiong C, Su P and Xiang W. In situ repair abilities of human umbilical cord-derived mesenchymal stem cells and autocrosslinked hyaluronic acid gel complex in rhesus monkeys with intrauterine adhesion. Sci Adv. 2020;6;eaba6357.
Diamond MP, Freeman ML. Clinical implications of postsurgical adhesions. Hum Reprod Update. 2001;7:567–76.
Zhang LP, Wang M, Shang X, Zhang Q, Yang BJ, Xu Y, Li JH, Feng LM. The incidence of placenta related disease after the hysteroscopic adhesiolysis in patients with intrauterine adhesions. Journal. 2020;59:575–9.
Baradwan S, Baradwan A, Bashir M and Al-Jaroudi D. The birth weight in pregnant women with Asherman syndrome compared to normal intrauterine cavity: A case-control study. Medicine (Baltimore). 2018;97(32);e11797.
Abbott J, Deans R. Accelerating the science after 125 years of treating intrauterine adhesions. Journal. 2020. https://doi.org/10.1016/j.jmig.2020.12.028.
Stamenov GS, Vitale SG, Della Corte L, Vilos GA, Parvanov DA, Nikolova DN, Ganeva RR and Haimovich S. Hysteroscopy and female infertility: a fresh look to a busy corner. Hum Fertil (Camb). 2020;1-29.
Yu D, Wong Y-M, Cheong Y, Xia E, Li T-C. Asherman syndrome-one century later. Fertil Steril. 2008;89:759–79.
Li C, Cai A, Sun C, Wu B, Chen X, Mao Y, Zhang Y, Gou Y, Yu J, Wang Y, Yu H, Wang J. The study on the safety and efficacy of amnion graft for preventing the recurrence of moderate to severe intrauterine adhesions. 2020;7;266-71.
Chen L, Zhang H, Wang Q, Xie F, Gao S, Song Y, Dong J, Feng H, Xie K, Sui L. Reproductive outcomes in patients with intrauterine adhesions following hysteroscopic adhesiolysis: experience from the largest women’s hospital in China. Journal. 2017;24:299–304.
Yang JH, Chen CD, Chen SU, Yang YS, Chen MJ. The influence of the location and extent of intrauterine adhesions on recurrence after hysteroscopic adhesiolysis. Journal. 2016;123:618–23.
Doroftei B, Dabuleanu AM, Ilie OD, Maftei R, Anton E, Simionescu G, Matei T and Armeanu T. Mini-Review of the New Therapeutic Possibilities in Asherman Syndrome-Where Are We after One Hundred and Twenty-Six Years? Diagnostics (Basel). 2020;10(9):706.
Di Guardo F, Della Corte L, Vilos GA, Carugno J, Török P, Giampaolino P, Manchanda R and Vitale SG. Evaluation and treatment of infertile women with Asherman syndrome: an updated review focusing on the role of hysteroscopy. Reprod Biomed Online. 2020;41(1);55–61.
Capmas P, Mihalache A, Duminil L, Hor LS, Pourcelot AG and Fernandez H. Intrauterine adhesions: What is the pregnancy rate after hysteroscopic management? J Gynecol Obstet Hum Reprod. 2020;49(7);101797.
Huang XW, Lin MM, Zhao HQ, Powell M, Wang YQ, Zheng RR, Ellis LB, Xia WT, Lin F. A prospective randomized controlled trial comparing two different treatments of intrauterine adhesions. Reprod Biomed Online. 2020;40:835–41.
Yang X, Liu Y, Li TC, Xia E, Xiao Y, Zhou F, Song D, Zhou Q. Durations of intrauterine balloon therapy and adhesion reformation after hysteroscopic adhesiolysis: a randomized controlled trial. Reprod Biomed Online. 2020;40:539–46.
Zhou Q, Shi X, Saravelos S, Huang X, Zhao Y, Huang R, Xia E, Li TC. Auto-cross-linked hyaluronic acid gel for prevention of intrauterine adhesions after hysteroscopic adhesiolysis: a randomized controlled trial. J Minim Invasive Gynecol. 2020. https://doi.org/10.1016/j.jmig.2020.06.030.
Zheng F, Xin X, He F, Liu J, Cui Y. Meta-analysis on the use of hyaluronic acid gel to prevent intrauterine adhesion after intrauterine operations. Exp Ther Med. 2020;19:2672–8.
Yao Q, Zheng YW, Lan QH, Wang LF, Huang ZW, Chen R, Yang Y, Xu HL, Kou L and Zhao YZ. Aloe/poloxamer hydrogel as an injectable β-estradiol delivery scaffold with multi-therapeutic effects to promote endometrial regeneration for intrauterine adhesion treatment. Eur J Pharm Sci. 2020;148;105316.
Huberlant S, Leprince S, Allegre L, Warembourg S, Leteuff I, Taillades H, Garric X, de Tayrac R, Letouzey V. In vivo evaluation of the efficacy and safety of a novel degradable polymeric film for the prevention of intrauterine adhesions. J Minim Invasive Gynecol. 2020. https://doi.org/10.1016/j.jmig.2020.10.025.
Kaczynski P, Bauersachs S, Goryszewska E, Baryla M, Waclawik A. Synergistic action of estradiol and PGE2 on endometrial transcriptome in vivo resembles pregnancy effects better than estradiol alone†. Biol Reprod. 2020. https://doi.org/10.1093/biolre/ioaa230.
Chang Y, Duan H, Shen X, Wang S, Guo Z, Chen S. Controversy in the management of oestrogen therapy before hysteroscopic adhesiolysis: a systematic review and meta-analysis. Reprod Biomed Online. 2020;41:715–23.
Li J, Huang B, Dong L, Zhong Y and Huang Z. WJ‑MSCs intervention may relieve intrauterine adhesions in female rats via TGF‑β1‑mediated Rho/ROCK signaling inhibition. Mol Med Rep. 2021;23(1):8.
Xin L, Lin X, Zhou F, Li C, Wang X, Yu H, Pan Y, Fei H, Ma L, Zhang S. A scaffold laden with mesenchymal stem cell-derived exosomes for promoting endometrium regeneration and fertility restoration through macrophage immunomodulation. Acta Biomater. 2020;113:252–66.
Park M, Hong SH, Park SH, Kim YS, Yang SC, Kim HR, Noh S, Na S, Lee HK, Lim HJ, Lyu SW, Song H. Perivascular stem cell-derived cyclophilin A improves uterine environment with Asherman’s syndrome via HIF1α-dependent angiogenesis. Mol Ther. 2020;28:1818–32.
Tan Q, Xia D, Ying X. miR-29a in Exosomes from bone marrow mesenchymal stem cells inhibit fibrosis during endometrial repair of intrauterine adhesion. Int J Stem Cells. 2020;13:414–23.
Ouyang X, You S, Zhang Y, Zhang C, Zhang G, Shao X, He F, Hu L. Transplantation of human amnion epithelial cells improves endometrial regeneration in rat model of intrauterine adhesions. Stem Cells Dev. 2020;29:1346–62.
Lin X, Zhang Y, Pan Y, He S, Dai Y, Zhu B, Wei C, Xin L, Xu W, Xiang C, Zhang S. Endometrial stem cell-derived granulocyte-colony stimulating factor attenuates endometrial fibrosis via sonic hedgehog transcriptional activator Gli2. Biol Reprod. 2018;98:480–90.
Peng J, Li M, Zeng H, Zeng Z, Huang J, Liang X. Intrauterine infusion of platelet-rich plasma is a treatment method for patients with intrauterine adhesions after hysteroscopy. Int J Gynaecol Obstet. 2020;151:362–5.
Zhang Z, Li S, Deng J, Yang S, Xiang Z, Guo H, Xi H, Sang M, Zhang W. Aspirin inhibits endometrial fibrosis by suppressing the TGF-β1-Smad2/Smad3 pathway in intrauterine adhesions. Int J Mol Med. 2020;45:1351–60.
Amer MI, Abd-El-Maeboud KH. Amnion graft following hysteroscopic lysis of intrauterine adhesions. J Obstet Gynaecol Res. 2006;32:559–66.
Chen Y, Liu L, Luo Y, Chen M, Huan Y and Fang R. Effects of Aspirin and Intrauterine Balloon on Endometrial Repair and Reproductive Prognosis in Patients with Severe Intrauterine Adhesion: A Prospective Cohort Study. Biomed Res Int. 2017;2017:8526104.
Zhang W, Tang N, Li X, George DM, He G, Huang T. The top 100 most cited articles on total hip arthroplasty: a bibliometric analysis. J Orthop Surg Res. 2019;14:412.
Borgatti SP, Mehra A, Brass DJ, Labianca G. Network analysis in the social sciences. Science. 2009;323:892–5.
Ahmad SS, Ahmad SS, Kohl S, Ahmad S, Ahmed AR. The hundred most cited articles in bariatric surgery. Obes Surg. 2015;25:900–9.
Schenker JG. Etiology of and therapeutic approach to synechia uteri. Eur J Obstet Gynecol Reprod Biol. 1996;65:109–13.
Khan Z, Goldberg JM. Hysteroscopic management of Asherman’s syndrome. J Minim Invasive Gynecol. 2018;25:218–28.
Cervelló I, Gil-Sanchis C, Santamaría X, Cabanillas S, Díaz A, Faus A, Pellicer A and Simón C. Human CD133(+) bone marrow-derived stem cells promote endometrial proliferation in a murine model of Asherman syndrome. Fertil Steril. 2015;104;1552–60.e1-3.
Sedgh G, Bearak J, Singh S, Bankole A, Popinchalk A, Ganatra B, Rossier C, Gerdts C, Tunçalp Ö, Johnson BR Jr, Johnston HB, Alkema L. Abortion incidence between 1990 and 2014: global, regional, and subregional levels and trends. Lancet. 2016;388:258–67.
Cameron S. Recent advances in improving the effectiveness and reducing the complications of abortion. F1000Res. 2018;7.
Guo C, Pang L, Wen X, Zheng X. Risky sexual behaviors and repeat induced abortion among unmarried young women in China: results from a large, nationwide, population-based sample. J Womens Health (Larchmt). 2019;28:1442–9.
Zong Z, Sun X, Mao J, Shu X, Hearst N. Contraception and abortion among migrant women in Changzhou, China. Eur J Contracept Reprod Health Care. 2020. https://doi.org/10.1080/13625187.2020.18209791-6.
Jiang Y, Han J, Donovan C, Ali G, Xu T, Zheng Y, Sun W. Induced abortion among Chinese women with living child-a national study. Adv Dis Control Prev. 2017;2:10–5.
Zeng Y, Hesketh T. The effects of China’s universal two-child policy. Lancet. 2016;388:1930–8.
Cao Y, Sun H, Zhu H, Zhu X, Tang X, Yan G, Wang J, Bai D, Wang J, Wang L, Zhou Q, Wang H, Dai C, Ding L, Xu B, Zhou Y, Hao J, Dai J and Hu Y. Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: a phase I clinical trial. Stem Cell Res Ther. 2018;9.
Lin N, Li Xa, Song T, Wang J, Meng K, Yang J, Hou X, Dai J and Hu Y. The effect of collagen-binding vascular endothelial growth factor on the remodeling of scarred rat uterus following full-thickness injury. Biomaterials. 2012;33(6);1801–7.
March CM, Israel R. Intrauterine adhesions secondary to elective abortion. Hysteroscopic diagnosis and management. Obstet Gynecol. 1976;48:422–4.
March CM, Israel R. Gestational outcome following hysteroscopic lysis of adhesions. Fertil Steril. 1981;36:455–9.
March CM, Israel R, March AD. Hysteroscopic management of intrauterine adhesions. Am J Obstet Gynecol. 1978;130:653–7.
Yang J-H, Chen M-J, Wu M-Y, Chao K-H, Ho H-N, Yang Y-S. Office hysteroscopic early lysis of intrauterine adhesion after transcervical resection of multiple apposing submucous myomas. Fertil Steril. 2008;89:1254–9.
Yang J-H, Chen M-J, Chen C-D, Chen S-U, Ho H-N and Yang Y-S. Optimal waiting period for subsequent fertility treatment after various hysteroscopic surgeries. Fertil Steril. 2013;99(7):2092–6.e3.
Takai IU, Kwayabura AS, Ugwa EA, Idrissa A, Obed JY, Bukar M. A 10-year review of the clinical presentation and treatment outcome of Asherman’s syndrome at a center with limited resources. Ann Med Health Sci Res. 2015;5:442–6.
Kou L, Jiang X, Xiao S, Zhao YZ, Yao Q, Chen R. Therapeutic options and drug delivery strategies for the prevention of intrauterine adhesions. J Control Release. 2020;318:25–37.
Berman JM. Intrauterine adhesions. Semin Reprod Med. 2008;26:349–55.
Santamaria X, Mas A, Cervello I, Taylor H, Simon C. Uterine stem cells: from basic research to advanced cell therapies. Hum Reprod Update. 2018;24:673–93.
Cao Y, Sun H, Zhu H, Zhu X, Tang X, Yan G, Wang J, Bai D, Wang J, Wang L, Zhou Q, Wang H, Dai C, Ding L, Xu B, Zhou Y, Hao J, Dai J, Hu Y. Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: a phase I clinical trial. Stem Cell Res Ther. 2018;9:192.
Chen L, Qu J and Xiang C. The multi-functional roles of menstrual blood-derived stem cells in regenerative medicine. Stem Cell Res Ther. 2019;10;
Ma H, Liu M, Li Y, Wang W, Yang K, Lu L, He M, Deng T, Li M, Wu D. Intrauterine transplantation of autologous menstrual blood stem cells increases endometrial thickness and pregnancy potential in patients with refractory intrauterine adhesion. J Obstet Gynaecol Res. 2020;46:2347–55.
Azizi R, Aghebati-Maleki L, Nouri M, Marofi F, Negargar S, Yousefi M. Stem cell therapy in Asherman syndrome and thin endometrium: stem cell- based therapy. Biomed Pharmacother. 2018;102:333–43.
Santamaria X, Liu JH, Aghajanova L, Isaacson K, Movilla P, Fernandez H, Capmas P, Donnez J, Simón C. Should we consider alternative therapies to operative hysteroscopy for the treatment of Asherman syndrome? Fertil Steril. 2020;113:511–21.
Koythong T, Guan X. Consideration for an optimal and practical approach to hysteroscopic adhesiolysis of intrauterine adhesions. Ann Transl Med. 2020;8:663.